This year’s General Hepatology Update will offer the latest information on the diagnosis and management of three relevant conditions commonly encountered in clinical practice: Wilson Disease, surgical risk assessment in cirrhotic patients, and hepatic encephalopathy.
Eve A. Roberts, MD, FAASLD, will help attendees recognize patients with Wilson Disease and provide a clinical-based approach for diagnosis and treatment.
“Wilson Disease is frequently in the differential diagnosis for elevated liver tests. It can mimic both neuropsychiatric disorders and liver disorders including autoimmune hepatitis and NASH,” said Rolland C. Dickson, MD, FAASLD, who along with Jacqueline Laurin, MD, is program chair. “Yet, it is often difficult to know who should be tested and how to interpret the results. Dr. Roberts will give an overview of the disease, update the criteria used to make and exclude the diagnosis as well as review the current treatment options.”
The second topic, presented by Patrick G. Northup, MD, MHES, will help clinicians assess the risk and provide guidance for management before and after procedures or surgical intervention.
“It is well known that patients with cirrhosis have an increased risk for surgical procedures,” said Dr. Dickson. “We are frequently required to weigh the risk and benefits of surgical interventions. Dr. Northup will review pre-operative and perioperative management issues in this population and provide an approach to risk stratification for non-liver major surgery in cirrhotic patients.”
The final presentation focuses on earlier recognition of hepatic encephalopathy, one of the most significant complications of end-stage liver disease.
“Jasmohan S. Bajaj, MD, FAASLD, will provide an overview of the pathophysiology of hepatic encephalopathy with a focus on a practical approach to diagnosis, prevention, and management,” said Dr. Laurin.